Schistosomiasis Drugs Market Poised for Steady Growth in the Future 2025
Report Overview and TOC @ https://www.transparencymarketresearch.com/schistosomiasis-drugs-market.html
Schistosomiasis symptoms occur when the body reacts to the worms' eggs. Diarrhea, abdominal cramps, blood in the stool, vomiting, liver enlargement, blood in urine, kidney damage, fever, rash, body aches,and weakness are signs and symptoms of the disease. Other chronic symptoms include vaginal bleeding, genital lesions, and nodules in the vulva, seminal vesicles, paralysis, seizures, Healthcare professionals recommend repeated examination to confirm the schistosomiasis parasite in the stool and urine. Blood test and polymerase chain reaction (PCR) tests also help to diagnose schistosomiasis. If no eggs are found in urine or feces other tests such as colonoscopy, endoscopy, ultrasound, echocardiograms, MRI, and liver biopsy can be recommended for better diagnosis. If schistosomiasis is left untreated, it can lead to complications related to cardiopulmonary, central nervous system, gastrointestinal, liver, spleen, bacterial infections, urinary obstruction, and even death.
Request brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30650
Currently, praziquantel drug is used to treat schistosomiasis and is more effective on adult worms; however, no effective medication is available in the market for eggs or immature worms. Corticosteroids are also used to treat the disease. Oxamniquine, artemisinins, metrifonate, and trioxolanes are other drugs to treat schistosomiasis, however these drugs are less effective, while a few others are under development. Surgical alternativescan include the removal of tumors, shunt surgeries, and granuloma removal. Increasing scarcity of clean water supplies in Africa, Asia, and Latin America increase the proliferation of the disease, impelling the schistosomiasis drugs market. Lack of the disease awareness is the key restraint of the market.
The schistosomiasis drugs market can be segmented based on drug class, distribution channel, end-user, and region. In terms of drug class, the market can be categorized into anthelmintic or anti-worm and others. Based on distribution channel the market is categorized into hospital pharmacy, retail pharmacy, and online sales. The hospital pharmacy segment held the largest share in the schistosomiasis drugs market. The segment is projected to expand at a significant CAGR during the forecast period. The online sales segment is expected to gain market share during the forecast period, due to the growing use of mobile-based applications for ordering medicines.
for Specific and Customized requirements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=30650
In terms of region, the global schistosomiasis drugs market can be segmented into Middle East & Africa, Latin America, Asia Pacific, Europe, and North America. Middle East & Africa is the largest market for schistosomiasis drugs, followed by Latin America, Asia, Europe, and North America. In terms of revenue, South Africa is a major contributor to the schistosomiasis drugs market in Middle East & Africa. The market in Latin America is expanding rapidly due to an increase in the patient population, especially in Brazil. However, Asia Pacific and Europe are projected to grow in the near future. Emerging economies such as China and Japan are projected to contribute to the regional growth due to better health care infrastructure, economic growth, improving insurance payers, expanding and developing private health care sector, and increasing awareness.
Key players operating in the global schistosomiasis drugs market are Bayer AG, Merck KGaA, Pfizer, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Teva Pharmaceuticals Industries Ltd., and Mylan N.V.
Pre Book full report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=31316<ype=S
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453
TMR Blog: http://www.theglobalhealthnews.com/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Schistosomiasis Drugs Market Poised for Steady Growth in the Future 2025 here
News-ID: 855922 • Views: 165
More Releases from Transparency Market Research
Distributed Operating System Market: A Latest Research Report to Share Industry …
A distributed operating system is a software which is a collection of distinct computational nodes that are networked, independent, and communicating in order to perform certain operations The distributed operating system manages the jobs that are serviced by multiple processing units. Every distinct node holds a precise software subset of the global collective operating system. Each subset is a composite of two distinct service provisions. The first subset is a universal kernel,
Research Outlines Huge Growth In Automatic Dependent Surveillance Broadcast Mark …
Automatic dependent surveillance-broadcast (ADS-B) is surveillance technology which enables an aircraft to determine its position through satellite navigation. Automatic dependent surveillance-broadcast (ADS-B) helps to track an aircraft through periodical broadcasts. As a replacement for secondary surveillance radar, automatic dependent surveillance - broadcast (ADS–B) technology can be used by air traffic control ground stations to gather information regarding tracking of the aircraft. It can also be used by other aircrafts to enable
RF Shielded Test Enclosures Market: Structure and Overview of Key Industry
RF shielded test enclosures, also called RF shielded test boxes, are used for testing of RF and microwave devices in an isolated test environment, which lacks interference of other devices as well as the external environment These test boxes are used in isolation from unintended electromagnetic interference in noisy surroundings. In order to check whether a device is functioning up to the mark in an isolated environment, these boxes are used
Pitot Tube Anemometers Market Will Escalate Rapidly in the Near Future
A pitot tube anemometer is a flow measurement device that is designed to measure and display air pressure, air velocity, volumetric flow, and air temperature Pitot tube anemometers involve use of the microprocessor technology for signal processing, which ensures quick and accurate measuring results Pitot tube anemometers are available in two types i.e. portable and fixed When not in use, a pitot tube anemometer should be placed in dry conditions and be protected
More Releases for Schistosomiasis
Schistosomiasis Therapeutics- Pipeline Analysis 2018
Schistosomiasis is an acute and chronic disease caused by parasitic worms of the genus Schistosoma, during routine domestic, occupational, agricultural, and recreational activities, which involves infested water exposure. Download the sample report @ https://www.pharmaproff.com/request-sample/1070 School children are more prone to schistosomiasis due to lack of hygiene and certain play habits, such as swimming or fishing in infested water. Symptoms of schistosomiasis are caused by the body’s reaction to the worms' eggs.
Schistosomiasis-Pipeline Review H2 2018
Schistosomiasis is a type of infection caused by parasites that live in fresh water, such as rivers or lakes. Symptoms include a high temperature, headache, cough, a dark red, blotchy, raised skin rash, pain in the abdomen and joint and muscle pain. Report Highlights Publisher's Pharmaceutical and Healthcare latest pipeline guide Schistosomiasis-Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Schistosomiasis (Infectious Disease), complete with analysis by
Schistosomiasis Treatment Market Opportunity Analysis, 2018-2026
Schistosomiasis is a disease caused by infection with freshwater parasitic worms. It can be acute or chronic infection mainly caused by parasitic worm’s blood flukes (trematode worms). There are two forms of schistosomiasis, such as intestinal and urogenital. According to the World Health Organization (WHO) reports in 2017, urogenital schistosomiasis is a high risk factor for the transmission of HIV infection in women. People usually get infected during agriculture, domestic,
Schistosomiasis - Pipeline Insight and Review, H1 2018
Market Research HUB has recently added a latest Pharmaceutical and Healthcare disease pipeline guide Schistosomiasis - Pipeline Review, H1 2018, provides an overview of the Schistosomiasis (Infectious Disease) pipeline landscape. Schistosomiasis is a type of infection caused by parasites that live in fresh water, such as rivers or lakes. Symptoms include a high temperature, headache, cough, a dark red, blotchy, raised skin rash, pain in the abdomen and joint and muscle
Schistosomiasis Pharmaceutical and Healthcare Pipeline Review H1
Summary Schistosomiasis is a type of infection caused by parasites that live in fresh water, such as rivers or lakes. Symptoms include a high temperature, headache, cough, a dark red, blotchy, raised skin rash, pain in the abdomen and joint and muscle pain. Report Highlights Pharmaceutical and Healthcare latest pipeline guide Schistosomiasis - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Schistosomiasis (Infectious Disease), complete with analysis by
Schistosomiasis Pipeline Review, H2 2017
"The Report Schistosomiasis - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schistosomiasis - Pipeline Review, H2 2017, provides an overview of the Schistosomiasis (Infectious Disease) pipeline landscape. Schistosomiasis is a type of infection caused by parasites that live in fresh water, such as rivers or lakes. Symptoms include